Revolutionizing Science.
Transforming Life.

“I like that this is not off the shelf. I explain that this is a treatment that uses the patient’s own tumor cells and that is exciting to patients – the idea of medically Immunizing them against their own tumor.”

Phase IIb Melanoma Clinical Trial Investigator



Discovering and developing new medicines comes with significant investment and a high risk of failure. At Orbis, we challenge conventional wisdom, innovate, and push the bounds of scientific discovery. We believe breakthrough thinking leads to new approaches that can overcome barriers and improve clinical outcomes.

Cancer is one of the deadliest diseases that arises from our own cells. This creates a very confusing situation for our immune system. To launch an immune response, the body has to be able to tell the difference between cells that are “self” and “non-self.” One reason cancer is so difficult to treat is that it avoids detection because the immune system thinks it is “self.” Without a way for the immune system to tell the difference between a healthy cell and a cancer cell, there is little the body can do to prevent cancer from taking over.

Orbis’ technology uses a proprietary particle delivery system that helps the body’s immune system recognize foreign invaders as “non-self” allowing it to seek out and to destroy cancer and other immune-mediated conditions. Orbis has developed a pipeline of immunotherapy-based products that are designed to harness the potent role of the body’s innate immune system to repair and to restore health.

Each of our product candidates have their own distinct clinical characteristics, target indications, commercialization potential, and partnering opportunities.


Translating Science into Medical Breakthroughs through colaboration

At Orbis, we are developing transformative medicines that have the potential improve the lives of people with immune-mediated conditions. We know that to bring the most innovative, effective and safe treatment options to patients, we need to go beyond our walls. To that end, we are actively seeking partners and licensing opportunities in the U.S. and around the world to explore the therapeutic potential of our personalized therapeutic cancer vaccines.

Learn More
Interested in partnersing with Orbis or one of our affiliates? Please contact Riley Polk at riley.polk@orbishealthsolutions.com.



We seek to create value for our investors through continuous innovation and growth

For investment information and investment opportunities in Orbis or one of its subsidiaries,
please contact Riley Polk at riley.polk@orbishealthsolutions.com.

We seek to create value for our investors through continuous innovation and growth


Join the Brightest at Orbis.
Greenville is undergoing tremendous growth within the biosciences industry, and as one of South Carolina’s premiere scientific research centers, Orbis has an unparalleled track record when it comes to clinical impact and excellence. Our researchers have collaborated to turn radical ideas into life-changing realities, from creating personalized therapeutic cancer vaccines to an immunology-based serum that regenerates and renews damaged skin. We are a patient- and purpose-driven organization united by a singular focus: a wholehearted commitment to changing the lives of patients and supporting each other on the journey. In everything we do, we strive to make a meaningful impact. If you are interested in career opportunities at Orbis or one of our affiliates, just write us a message via the contact form. We look forward to hearing from you!


We’d love to hear from you!
Orbis Health Solutions

111 Smith Hines Road Suite E, Greenville, South Carolina 29607, United States.